Director Global Marketing – HS Scientific Strategy Lead
Job in
North Wales, Montgomery County, Pennsylvania, 19454, USA
Listing for:
Merck Sharp & Dohme (MSD)
Full Time
position
Listed on 2026-11-20
Job specializations:
-
Science
Job Description & How to Apply Below
Job Description It is an exciting time to join our company Global Immunology team as we aspire to become a trusted leader in delivering novel solutions and precision medicine that transform the standard of care for immune-mediated diseases. Immunology is a top corporate priority and a key future growth driver for the company.
Our investigational therapy is a monoclonal antibody directed to tumor necrosis factor-like cytokine 1A (TL1A). Following positive Phase 2b results in hidradenitis suppurativa (HS), the program is advancing toward Phase 3 and global launch readiness. The HS programme represents an important potential growth opportunity within our company expanding Immunology portfolio. HS is a chronic, painful and potentially progressive inflammatory-skin disease characterized by nodules, abscesses, draining tunnels, scarring and substantial psychosocial burden.
The HS Scientific Strategy Lead will lead the commercial scientific strategy for our investigational therapy in HS, translating complex science, clinical evidence and customer insight into a clear, differentiated and credible scientific narrative. The role will operate at the intersection of Commercial, Medical Affairs, Clinical Development, Outcomes Research, Global Market Access, Policy and priority markets to ensure that evidence generation and scientific engagement support the global commercial ambition, Phase 3 program and launch readiness.
This position reports to the Executive Director, Global Commercial Lead, Hidradenitis Suppurativa.
Primary responsibilities:
Lead the development and evolution of the global commercial scientific strategy for tulisokibart in HS, ensuring alignment with the integrated global brand strategy and broader Dermatology ambition.
Develop a clear, concise and differentiated scientific narrative for TL1A and the potential immuno-fibrotic biology in HS, translating complex evidence into audience-appropriate communication without over-claiming beyond the data.
Partner with Medical Affairs, Clinical Development, Research Laboratories, Outcomes Research and Global Market Access to identify and prioritise evidence gaps that may influence treatment positioning, access and commercial value.
Represent Commercial in evidence-planning forums and provide commercial input into Phase 3 design, endpoints, patient-relevant outcomes, sub-populations and supporting evidence-generation plans.
Lead the commercial scientific landscape assessment, including treatment guidelines, evolving endpoints, competitive mechanisms and emerging standards of disease control in HS.Develop the global scientific leader engagement strategy in partnership with Medical Affairs, including expert mapping, insight plans, scientific input forums and engagement with HS, dermatology, surgery and multidisciplinary-care experts.
Partner with Medical Affairs to design and execute Scientific Expert Input forums that test the development plan, scientific narrative, value hypotheses and evidence priorities.
Lead the commercial congress strategy and cross-functional congress planning, including scientific priorities, insight generation, competitor monitoring, internal briefings and senior leadership scientific engagements.
Partner with Value & Implementation colleagues, US and priority international markets to ensure that evidence priorities reflect clinical practice, access environments and implementation barriers.
Create the scientific communication roadmap supporting Phase 3 milestones and launch readiness, ensuring consistency across global, regional and local teams.
Support external engagement strategy with professional societies, guideline stakeholders, patient organisations and other external partners, in collaboration with Medical, Policy and Communications.
Apply advanced analytics, AI-enabled insight synthesis and structured decision-making to identify emerging evidence, competitor activity and strategic implications.
Manage relevant agency relationships, projects and budget, ensuring high-quality delivery against agreed milestones.
Contribute to early Dermatology pipeline and business development assessments by evaluating scientific differentiation, evidence requirements and strategic fit.
Establish clear scientific-strategy deliverables, decision milestones and success measures; regularly communicate progress, risks and recommendations to the Global Commercial Lead, HS and the cross-functional leadership team.
Partner with the HCP Strategy Lead to ensure that the scientific…
To View & Apply for jobs on this site that accept applications from your location or country, tap the button below to make a Search.
(If this job is in fact in your jurisdiction, then you may be using a Proxy or VPN to access this site, and to progress further, you should change your connectivity to another mobile device or PC).
View / Apply for Jobs
Matching My Jurisdiction
(If this job is in fact in your jurisdiction, then you may be using a Proxy or VPN to access this site, and to progress further, you should change your connectivity to another mobile device or PC).
View / Apply for Jobs
Matching My Jurisdiction